Back to
BAILLIE GIFFORD & CO
DNLI30 quarters
Position history for
BAILLIE GIFFORD & CO's holdings in DENALI THERAPEUTICS INC
BAILLIE GIFFORD & CO holds 12M shares of DNLI (DENALI THERAPEUTICS INC), worth $307.6M as of 2026-Q2. The position was decreased (-0.9% shares). DNLI represents 0.3% of BAILLIE GIFFORD & CO's portfolio.
Current Value
$307.6M
Current Shares
12M
Total Value Change
+$162.2M
Total Shares Change
+5.7M
Quarter-by-Quarter History
Other major holders of DNLI: BNP PARIBAS FINANCIAL MARKETS, Temasek Holdings (Private) Ltd, BlackRock, Inc., VANGUARD GROUP INC